Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat

Metabolism ◽  
1987 ◽  
Vol 36 (8) ◽  
pp. 807-814 ◽  
Author(s):  
Gayle Crozier ◽  
Brigitte Bois-Joyeux ◽  
Marc Chanez ◽  
Jean Girard ◽  
Jean Peret
1972 ◽  
Vol 14 (4) ◽  
pp. 203-209 ◽  
Author(s):  
A. Bach ◽  
D. Guisard ◽  
P. Metais ◽  
G. Debry

1991 ◽  
Vol 121 (5) ◽  
pp. 585-594 ◽  
Author(s):  
Marc Chanez ◽  
Brigitte Bois-Joyeux ◽  
Maurice J. Arnaud ◽  
Jean Peret

Nutrients ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1269 ◽  
Author(s):  
Ayumi Fukazawa ◽  
Atsuko Koike ◽  
Takuya Karasawa ◽  
Momoko Tsutsui ◽  
Saki Kondo ◽  
...  

Long-term intake of a ketogenic diet enhances utilization of ketone bodies, a particularly energy-efficient substrate, during exercise. However, physiological adaptation to an extremely low-carbohydrate diet has been shown to upregulate pyruvate dehydrogenase kinase 4 (PDK4, a negative regulator of glycolytic flux) content in skeletal muscle, resulting in impaired high-intensity exercise capacity. This study aimed to examine the effects of a long-term ketogenic diet containing medium-chain triglycerides (MCTs) on endurance training-induced adaptations in ketolytic and glycolytic enzymes of rat skeletal muscle. Male Sprague-Dawley rats were placed on either a standard diet (CON), a long-chain triglyceride-containing ketogenic diet (LKD), or an MCT-containing ketogenic diet (MKD). Half the rats in each group performed a 2-h swimming exercise, 5 days a week, for 8 weeks. Endurance training significantly increased 3-oxoacid CoA transferase (OXCT, a ketolytic enzyme) protein content in epitrochlearis muscle tissue, and MKD intake additively enhanced endurance training–induced increases in OXCT protein content. LKD consumption substantially increased muscle PDK4 protein level. However, such PDK4 increases were not observed in the MKD-fed rats. In conclusion, long-term intake of ketogenic diets containing MCTs may additively enhance endurance training–induced increases in ketolytic capacity in skeletal muscle without exerting inhibitory effects on carbohydrate metabolism.


2013 ◽  
Vol 34 (1) ◽  
pp. 153-160 ◽  
Author(s):  
Tanya S McDonald ◽  
Kah Ni Tan ◽  
Mark P Hodson ◽  
Karin Borges

Medium chain triglycerides (MCTs) are used to treat neurologic disorders with metabolic impairments, including childhood epilepsy and early Alzheimer's disease. However, the metabolic effects of MCTs in the brain are still unclear. Here, we studied the effects of feeding even and uneven MCTs on brain glucose metabolism in the mouse. Adult mice were fed 35% (calories) of trioctanoin or triheptanoin (the triglycerides of octanoate or heptanoate, respectively) or a matching control diet for 3 weeks. Enzymatic assays and targeted metabolomics by liquid chromatography tandem mass spectrometry were used to quantify metabolites in extracts from the hippocampal formations (HFs). Both oils increased the levels of β-hydroxybutyrate, but no other significant metabolic alterations were observed after triheptanoin feeding. The levels of glucose 6-phosphate and fructose 6-phosphate were increased in the HF of mice fed trioctanoin, whereas levels of metabolites further downstream in the glycolytic pathway and the pentose phosphate pathway were reduced. This indicates that trioctanoin reduces glucose utilization because of a decrease in phosphofructokinase activity. Trioctanoin and triheptanoin showed similar anticonvulsant effects in the 6 Hz seizure model, but it remains unknown to what extent the anticonvulsant mechanism(s) are shared. In conclusion, triheptanoin unlike trioctanoin appears to not alter glucose metabolism in the healthy brain.


2001 ◽  
Vol 20 (1) ◽  
pp. 11-19 ◽  
Author(s):  
Nancy Nevin-Folino ◽  
Jeffrey Loughead ◽  
Melinda Loughead

The long-term developmental impact of nutrition on the preterm newborn has recently been shown to be of even greater importance than previously recognized. Very immature or ill infants are challenged by the need for a high caloric intake, but are unable to tolerate large fluid volumes. These patients may require enhanced-calorie formulas to achieve the desired growth goals. Formula enhancement has traditionally been performed by uniquely developed recipes of base formula concentration with the addition of powdered formula or single components such as medium-chain triglycerides oil, protein, or polycose. These mixtures have been largely unstudied for bioavailability, long-term outcomes, and tolerance. Deviation from recommended protein, fat, carbohydrate, mineral, and vitamin delivery limits may impair growth or lead to undesirable side effects. The practitioner must have an understanding of when and how to use an enhanced formula and the important monitoring and assessment needs of the patient receiving enhanced-calorie formula.


Metabolism ◽  
1991 ◽  
Vol 40 (5) ◽  
pp. 484-490 ◽  
Author(s):  
E.Scott Swenson ◽  
Kelley M. Selleck ◽  
Vigen K. Babayan ◽  
George L. Blackburn ◽  
Bruce R. Bistrian

Sign in / Sign up

Export Citation Format

Share Document